Search Results - "Bresse, Xavier"
-
1
Epidemiological and economic burden of potentially HPV-related cancers in France
Published in PloS one (20-09-2018)“…Human papillomaviruses (HPV) infection is now known to be responsible for almost all cervical cancers, and for a substantial fraction of Head and Neck cancers…”
Get full text
Journal Article -
2
Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France
Published in PloS one (13-02-2020)“…Until 2018, cervical cancer screening in France was an unorganized individual screening, with the exception of some pilot programs in some territories. We…”
Get full text
Journal Article -
3
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
Published in BMC cancer (08-01-2013)“…HPV is related to a number of cancer types, causing a considerable burden in both genders in Europe. Female vaccination programs can substantially reduce the…”
Get full text
Journal Article -
4
Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland
Published in Human vaccines (01-07-2011)“…A life-attenuated vaccine aimed at preventing herpes zoster (HZ) and its main complication, post-herpetic neuralgia (PHN), will soon be available in Europe…”
Get full text
Journal Article -
5
Loss of chance associated with sub-optimal HPV vaccination coverage rate in France
Published in Papillomavirus research (01-06-2017)“…Since 2007, HPV vaccination programs have been implemented in Europe. Significant real-life impact has already been reported in countries where the programs…”
Get full text
Journal Article -
6
Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
Published in Vaccine (08-01-2021)“…•In France, gender-neutral vaccination could have a significant public health impact.•GNV could avoid 17,000 cancers and over 1 million of genital warts…”
Get full text
Journal Article -
7
Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
Published in Expert review of pharmacoeconomics & outcomes research (01-04-2014)“…The International Agency for Research on Cancer acknowledges that HPV is a human carcinogen affecting both sexes. This study aimed to evaluate the public…”
Get more information
Journal Article -
8
Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination?
Published in Vaccine (24-06-2014)“…Highlights • Economic studies do not capture all the value of universal HPV vaccination. • Most studies capture the value of health gains but a fraction of…”
Get full text
Journal Article -
9
Role of vaccination in the sustainability of healthcare systems
Published in Journal of market access & health policy (2015)“…The use of vaccines to prevent diseases in children, adults, and the elderly results in fewer medical visits, diagnostic tests, treatments, and…”
Get full text
Journal Article -
10
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis
Published in Expert review of pharmacoeconomics & outcomes research (01-06-2013)“…This study assesses the cost-effectiveness of vaccination against herpes zoster (HZ) and postherpetic neuralgia in France, using a published Markov model. The…”
Get more information
Journal Article -
11
A comparative public health and budget impact analysis of pneumococcal vaccines: The French case
Published in Human vaccines & immunotherapeutics (02-09-2015)“…In 2002, a pneumococcal conjugate vaccine (PCV) was introduced to French infants and toddlers. A change has been witnessed in the incidence of pneumococcal…”
Get full text
Journal Article -
12
A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus
Published in Human vaccines & immunotherapeutics (01-11-2013)“…A critical review of cost-effectiveness analyses of HPV vaccination in males was conducted and nine studies were identified in different countries. Due to the…”
Get full text
Journal Article -
13
Cost-effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
Published in Expert review of pharmacoeconomics & outcomes research (01-10-2012)“…The introduction of routine infant vaccination against pneumococcal disease has resulted in a decreased overall invasive pneumococcal disease incidence in…”
Get more information
Journal Article -
14
A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
Published in Human vaccines & immunotherapeutics (01-04-2013)“…The aim was to compare the epidemiological and economic impact of 16/18 bivalent and 6/11/16/18 quadrivalent HPV vaccination in France, considering differences…”
Get full text
Journal Article -
15
A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany
Published in Expert review of pharmacoeconomics & outcomes research (01-10-2012)“…To assess the comparative public health and budget impact over 5 years of several pneumococcal vaccination strategies (23-valent pneumococcal polysaccharide…”
Get more information
Journal Article -
16
How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs)
Published in Therapie (01-02-2019)“…A flagship recommendation of the citizen's steering committee on immunization, the mandatory immunization for infants extended to 11 vaccines, introduced in…”
Get more information
Journal Article -
17
What is the budget impact of a new treatment or new health technology arriving on the market?
Published in Therapie (01-02-2017)“…In France, market access for innovative drugs (level I, II & III improvement of medical service rendered having significant impact on health insurance…”
Get more information
Journal Article -
18
Activity and cost related to hospital management of herpes zoster in France: focus on ophthalmic herpes zoster
Published in Gériatrie et psychologie neuropsychiatrie du vieillissement (01-12-2014)“…Herpes zoster secondary to reactivation and replication of the varicella zoster virus (VZV) caused a painful disease which impact the quality of life. Among…”
Get full text
Journal Article -
19
Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis
Published in Joint, bone, spine : revue du rhumatisme (01-01-2010)“…Abstract Objectives To compare effectiveness, associated cost of outcomes and cost-effectiveness of a single annual infusion of zoledronic acid versus current…”
Get full text
Journal Article -
20